FLGT
FLGT
NASDAQ · Health Care

Fulgent Genetics Inc

$19.14
+0.59 (+3.18%)
As of Aug 9, 10:17 PM ET ·
Financial Highlights (FY 2026)
Revenue
287.12M
Net Income
-53,845,376
Gross Margin
40.6%
Profit Margin
-18.8%
Rev Growth
-19.5%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 40.6% 40.6% 39.4% 39.4%
Operating Margin -31.3% -28.2% 19.5% 19.5%
Profit Margin -18.8% -17.8% 13.5% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 287.12M 356.75M 242.23M 275.80M
Gross Profit 116.45M 144.70M 95.53M 108.77M
Operating Income -89,895,735 -100,529,524 47.17M 53.86M
Net Income -53,845,376 -60,214,759 32.57M 36.27M
Gross Margin 40.6% 40.6% 39.4% 39.4%
Operating Margin -31.3% -28.2% 19.5% 19.5%
Profit Margin -18.8% -17.8% 13.5% 13.2%
Rev Growth -19.5% -19.5% -1.5% -4.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 651.5K 651.5K 257.54M 237.86M
Total Equity 260.61M 260.61M 521.51M 552.15M
D/E Ratio 0.00 0.00 0.49 0.43
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -82,742,559 -97,670,764 59.74M 74.06M
Free Cash Flow 22.63M 30.51M